Orion

Contact
orion.fi
+358104261

Orion Corporation

Orionintie 1A
02200 Espoo
Finland
+358104261
orion.fi
Contact
Profile News
Contact

About Orion

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion's net sales in 2019 amounted to EUR 1,051 million and the company had about 3,200 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

Read more about Orion
Facts about Orion
  • Focus : Manufacturer
  • Industry : Pharma

News about Orion

Orion

03-Jul-2012 | business & finance

Selvita and Orion Pharma Achieve a Research Milestone in Alzheimer’s Disease Program

Selvita S.A. announced that its collaboration with Orion Corporationon SEL103 program, for the symptomatic treatment of Alzheimer’s disease has reached the ...

Read news
Orion

26-Jul-2011 | research and development

Orion receives positive CHMP opinion for new intensive care sedative, dexdor® (dexmedetomidine)

Orion Corporation has received information that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued ...

Read news
Orion

09-Jul-2010 | business & finance

Selvita And Orion Pharma Will Collaborate on SEL103 - Alzheimer’s Disease Program

Selvita sp. z o.o. and Orion Corporation from Espoo, Finland announced that they have entered into a global collaboration to jointly develop and ...

Read news
Orion

29-Apr-2010 | research and development

Surface hygiene test wins the Chemical Industry Innovation Award

Surface hygiene is a major food safety and healthcare challenge across the world. Orion Diagnostica Oy and VTT Technical Research Centre of Finland have ...

Read news
Orion

21-Jan-2010 | science

Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched

An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic- ...

Read news
Orion

08-Sep-2009 | politics & laws

Orion and Hospira,Inc. sue Sandoz companies in the U.S. to enforce their U.S. Patents covering the proprietary drug Precedex

Orion Corporation and Hospira, Inc. filed together a patent infringement lawsuit in the United States to enforce Orion's U.S. Patent No.4,910,214 and Orion ...

Read news
Orion

28-Jan-2008 | research and development

Orion: Positive primary endpoint from FIRST-STEP study with Stalevo in early Parkinson's Disease

Orion Corporation has been informed by its marketing partner Novartis about the positive outcome of FIRST-STEP, a Phase 3 clinical study conducted by ...

Read news
Orion

27-Apr-2007 | research and development

Orion's partner discontinues development of levosimendan (Simdax) in the US

Orion has been informed by Abbott, the license holder for the intravenously administered formulation of levosimendan (trade name Simdax), an Orion- ...

Read news
Show more news about Orion

Here you will find Orion Corporation